These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 8517914)
1. Synthesis and biological activity of novel thymidine derivatives of podophyllotoxin and 4'-demethylepipodophyllotoxin. Derry WB; Pamidi CC; Gupta RS Anticancer Drug Des; 1993 Jun; 8(3):203-21. PubMed ID: 8517914 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological activities of the C-4 esters of 4'-demethylepipodophyllotoxin. Gupta RS; Chenchaiah PC Anticancer Drug Des; 1987 Aug; 2(1):13-23. PubMed ID: 3449082 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationships among glycosidic derivatives of 4'-demethylepipodophyllotoxin and epipodophyllotoxin, showing VM26- and VP16-213-like activities. Gupta RS; Chenchaiah PC; Gupta R Anticancer Drug Des; 1987 Aug; 2(1):1-12. PubMed ID: 3449081 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological activity of galactopyranoside derivatives of 4'-demethylepipodophyllotoxin showing VP-16 (etoposide)-like activity. Pamidi CC; Derry WB; Gupta RS Anticancer Drug Des; 1991 Nov; 6(5):481-93. PubMed ID: 1764166 [TBL] [Abstract][Full Text] [Related]
5. Podophyllotoxin-resistant mutants of Chinese hamster ovary cells: cross-resistance studies with various microtubule inhibitors and podophyllotoxin analogues. Gupta RS Cancer Res; 1983 Feb; 43(2):505-12. PubMed ID: 6848174 [TBL] [Abstract][Full Text] [Related]
6. 4'-Demethylepipodophyllotoxin-beta-D-glucoside: a new podophyllotoxin derivative with VM-26-like and VP-16-213-like activities. Gupta RS; Singh B J Natl Cancer Inst; 1984 Jul; 73(1):241-8. PubMed ID: 6588229 [TBL] [Abstract][Full Text] [Related]
7. Cross-resistance of nocodazole-resistant mutants of CHO cells toward other microtubule inhibitors: similar mode of action of benzimidazole carbamate derivatives and NSC 181928 and TN-16. Gupta RS Mol Pharmacol; 1986 Aug; 30(2):142-8. PubMed ID: 3736539 [TBL] [Abstract][Full Text] [Related]
8. Structure-function studies with derivatives of 6-benzyl-1,3-benzodioxole, a new class of synthetic compounds which inhibit tubulin polymerization and mitosis. Batra JK; Jurd L; Hamel E Mol Pharmacol; 1985 Jan; 27(1):94-102. PubMed ID: 3965931 [TBL] [Abstract][Full Text] [Related]
9. Linker length in podophyllotoxin-acridine conjugates determines potency in vivo and in vitro as well as specificity against MDR cell lines. Rothenborg-Jensen L; Hansen HF; Wessel I; Nitiss JL; Schmidt G; Jensen PB; Sehested M; Jensen LH Anticancer Drug Des; 2001 Dec; 16(6):305-15. PubMed ID: 12375883 [TBL] [Abstract][Full Text] [Related]
10. Applying linear interaction energy method for binding affinity calculations of podophyllotoxin analogues with tubulin using continuum solvent model and prediction of cytotoxic activity. Alam MA; Naik PK J Mol Graph Model; 2009; 27(8):930-43. PubMed ID: 19286405 [TBL] [Abstract][Full Text] [Related]
11. Requirements for P-glycoprotein recognition based on structure-activity relationships in the podophyllotoxin series. Etievant C; Schambel P; Guminski Y; Barret JM; Imbert T; Hill BT Anticancer Drug Des; 1998 Jun; 13(4):317-36. PubMed ID: 9627671 [TBL] [Abstract][Full Text] [Related]
12. Correlation of tubulin-binding and antitumor activities of podophyllotoxin analogs. Kelleher JK Cancer Treat Rep; 1978 Oct; 62(10):1443-7. PubMed ID: 101303 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptor. Baraldi PG; Romagnoli R; Pavani MG; Nuñez Mdel C; Tabrizi MA; Shryock JC; Leung E; Moorman AR; Uluoglu C; Iannotta V; Merighi S; Borea PA J Med Chem; 2003 Feb; 46(5):794-809. PubMed ID: 12593659 [TBL] [Abstract][Full Text] [Related]
14. Structure-activity study of the inhibition of microtubule assembly in vitro by podophyllotoxin and its congeners. Loike JD; Brewer CF; Sternlicht H; Gensler WJ; Horwitz SB Cancer Res; 1978 Sep; 38(9):2688-93. PubMed ID: 679171 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and cytotoxic activity of novel derivatives of 4'-demethylepipodophyllotoxin. Chen SW; Tian X; Tu YQ Bioorg Med Chem Lett; 2004 Oct; 14(20):5063-6. PubMed ID: 15380199 [TBL] [Abstract][Full Text] [Related]
16. Identification of 2-benzimidazolyl urea as a new antimitotic compound based on cross resistance studies with nocodazole resistance mutants of CHO cells. Gupta RS Biochem Biophys Res Commun; 1987 Feb; 143(1):225-32. PubMed ID: 3827918 [TBL] [Abstract][Full Text] [Related]
17. Genetic, biochemical, and cross-resistance studies with mutants of Chinese hamster ovary cells resistant to the anticancer drugs, VM-26 and VP16-213. Gupta RS Cancer Res; 1983 Apr; 43(4):1568-74. PubMed ID: 6831403 [No Abstract] [Full Text] [Related]
18. Structure of 4'-demethylepipodophyllotoxin in complex with tubulin provides a rationale for drug design. Niu L; Wang Y; Wang C; Wang Y; Jiang X; Ma L; Wu C; Yu Y; Chen Q Biochem Biophys Res Commun; 2017 Nov; 493(1):718-722. PubMed ID: 28864414 [TBL] [Abstract][Full Text] [Related]
19. Antioxidative and antitumor activity of derivatives of 4-beta-amino-4'-demethylepipodophyllotoxin and their structure-activity relationship. Zhang XY; Li WG; Wu YJ; Tian X Pharmazie; 2007 Jun; 62(6):432-8. PubMed ID: 17663190 [TBL] [Abstract][Full Text] [Related]
20. Antitumor agents. 234. Design, synthesis, and biological evaluation of novel 4beta-[(4' '-benzamido)-amino]-4'-o-demethyl-epipodophyllotoxin derivatives. Xiao Z; Bastow KF; Vance JR; Sidwell RS; Wang HK; Chen MS; Shi Q; Lee KH J Med Chem; 2004 Oct; 47(21):5140-8. PubMed ID: 15456257 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]